Endo pain drug linked with blood disorder when abused; Novartis drops long-acting Fanapt;

@FiercePharma: How is the U.K.'s fund for NICE-nixed cancer drugs faring? Total spent since 10/2010: £180.9M on 18K+ patients. Report | Follow @FiercePharma

> Endo Pharmaceuticals' ($ENDP) painkiller Opana can trigger a potentially fatal blood disorder if crushed and injected, one common method of pain-drug abuse. Report

> Novartis ($NVS) dropped development of a long-acting version of the antipsychotic drug Fanapt, after sales of the original version failed to live up to initial enthusiasm. Report

> Boehringer Ingelheim's clot-dissolving drug Actilyse got a boost from U.K. cost-effectiveness watchdogs, who broadened the potential treatment window for stroke patients. Report

> A drug shortage led to a tenfold increase in IV-related infections in hospitalized children, a study found. Report

> Teva Pharmaceutical Industries ($TEVA) supplier Venus Remedies is expected to see increased growth as resistant germs spur depand for its antibiotic combo drugs. Report

Biotech News

 @FierceBiotech: Alzheimer's drug builds new brain cell connections in rats. Story | Follow @FierceBiotech

 @JohnCFierce: New FDA lung cancer OK for Celgene's Abraxane should boost sales. More | Follow @JohnCFierce

 @RyanMFierce: Biotech regulars should appreciate this: Actress Jennifer Aniston investing in a Bob Langer company. More | Follow @RyanMFierce

> Intercept Pharma, Kythera Bio jump out of the IPO gate. Story

> NPS Pharma shares jump on upbeat FDA review of Gattex. News

> Vertex's new data on CF drug cocktail doesn't disappoint. Report

 @FierceMedDev: Coming soon: we'll find out if Intuitive Surgical's earnings slowed in Q3 as predicted. Let the speculation begin. More | Follow @FierceMedDev

 @MarkHFierce: Medtech industry's efficiency reaches new level, PwC report concludes. Article | Follow @MarkHFierce

 @DamianFierce: A federal court has tossed Fresenius' $83M Medicare fraud judgement. More  | Follow @DamianFierce

> FDA approves aortic-repair stent grafts. Article

> As it turns to medtech, Sony's credit rating gets lowered. Report

And Finally... Younger women suffering from chemotherapy-related menopause may get aid from talk therapy and exercise, a study found. Report

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.